These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 37660932)
1. DCLK1 and tuft cells: Immune-related functions and implications for cancer immunotherapy. Ding L; Weygant N; Ding C; Lai Y; Li H Crit Rev Oncol Hematol; 2023 Nov; 191():104118. PubMed ID: 37660932 [TBL] [Abstract][Full Text] [Related]
2. Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment. Cao Z; Weygant N; Chandrakesan P; Houchen CW; Peng J; Qu D Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348546 [TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments. Wu X; Qu D; Weygant N; Peng J; Houchen CW Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31979136 [TBL] [Abstract][Full Text] [Related]
4. DCLK1 and its oncogenic functions: A promising therapeutic target for cancers. Ye L; Liu B; Huang J; Zhao X; Wang Y; Xu Y; Wang S Life Sci; 2024 Jan; 336():122294. PubMed ID: 38007147 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-195 regulates Tuft cell function in the intestinal epithelium by altering translation of DCLK1. Kwon MS; Chung HK; Xiao L; Yu TX; Wang SR; Piao JJ; Rao JN; Gorospe M; Wang JY Am J Physiol Cell Physiol; 2021 Jun; 320(6):C1042-C1054. PubMed ID: 33788631 [TBL] [Abstract][Full Text] [Related]
6. Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. Zhang Y; Zoltan M; Riquelme E; Xu H; Sahin I; Castro-Pando S; Montiel MF; Chang K; Jiang Z; Ling J; Gupta S; Horne W; Pruski M; Wang H; Sun SC; Lozano G; Chiao P; Maitra A; Leach SD; Kolls JK; Vilar E; Wang TC; Bailey JM; McAllister F Gastroenterology; 2018 Jul; 155(1):210-223.e3. PubMed ID: 29604293 [TBL] [Abstract][Full Text] [Related]
7. Regulatory network analysis of Valenti G; Laise P; Takahashi R; Wu F; Ruan T; Vasciaveo A; Jiang Z; Sunagawa M; Middelhoff M; Nienhüser H; Fu N; Malagola E; Hayakawa Y; Iuga AC; Califano A; Wang TC bioRxiv; 2024 Oct; ():. PubMed ID: 39257805 [No Abstract] [Full Text] [Related]
8. The critical roles and therapeutic implications of tuft cells in cancer. Li L; Ma M; Duan T; Sui X Front Pharmacol; 2022; 13():1047188. PubMed ID: 36569325 [TBL] [Abstract][Full Text] [Related]
9. Sox9, Hopx, and survivin and tuft cell marker DCLK1 expression in normal canine intestine and in intestinal adenoma and adenocarcinoma. Reineking W; Schauerte IE; Junginger J; Hewicker-Trautwein M Vet Pathol; 2022 May; 59(3):415-426. PubMed ID: 35220825 [TBL] [Abstract][Full Text] [Related]
11. Tuft Cells: A New Player in Hirschsprung's Disease. O'Donnell AM; Nakamura H; Puri P Eur J Pediatr Surg; 2020 Feb; 30(1):59-63. PubMed ID: 31707728 [TBL] [Abstract][Full Text] [Related]
12. A novel serotonin-containing tuft cell subpopulation in mouse intestine. Cheng X; Voss U; Ekblad E Cell Tissue Res; 2019 May; 376(2):189-197. PubMed ID: 30666535 [TBL] [Abstract][Full Text] [Related]
13. Notch signaling drives development of Barrett's metaplasia from Dclk1-positive epithelial tuft cells in the murine gastric mucosa. Kunze B; Middelhoff M; Maurer HC; Agibalova T; Anand A; Bührer AM; Fang HY; Baumeister T; Steiger K; Strangmann J; Schmid RM; Wang TC; Quante M Sci Rep; 2021 Feb; 11(1):4509. PubMed ID: 33627749 [TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of DCLK1 in cancer and cancer stem cells. Chhetri D; Vengadassalapathy S; Venkadassalapathy S; Balachandran V; Umapathy VR; Veeraraghavan VP; Jayaraman S; Patil S; Iyaswamy A; Palaniyandi K; Gnanasampanthapandian D Front Mol Biosci; 2022; 9():965730. PubMed ID: 36250024 [TBL] [Abstract][Full Text] [Related]
15. Functional implication of Dclk1 and Dclk1-expressing cells in cancer. Westphalen CB; Quante M; Wang TC Small GTPases; 2017 Jul; 8(3):164-171. PubMed ID: 27458755 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma. Ge Y; Liu H; Zhang Y; Liu J; Yan R; Xiao Z; Fan X; Huang X; An G Transl Oncol; 2022 Mar; 17():101317. PubMed ID: 34998236 [TBL] [Abstract][Full Text] [Related]
17. Dclk1-expressing tuft cells: critical modulators of the intestinal niche? Middelhoff M; Westphalen CB; Hayakawa Y; Yan KS; Gershon MD; Wang TC; Quante M Am J Physiol Gastrointest Liver Physiol; 2017 Oct; 313(4):G285-G299. PubMed ID: 28684459 [No Abstract] [Full Text] [Related]
18. DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer. Vijai M; Baba M; Ramalingam S; Thiyagaraj A Oncol Lett; 2021 Dec; 22(6):850. PubMed ID: 34733368 [TBL] [Abstract][Full Text] [Related]
19. Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling. Liu H; Yan R; Xiao Z; Huang X; Yao J; Liu J; An G; Ge Y Breast Cancer Res; 2023 Apr; 25(1):43. PubMed ID: 37069669 [TBL] [Abstract][Full Text] [Related]
20. Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal. Chandrakesan P; May R; Qu D; Weygant N; Taylor VE; Li JD; Ali N; Sureban SM; Qante M; Wang TC; Bronze MS; Houchen CW Oncotarget; 2015 Oct; 6(31):30876-86. PubMed ID: 26362399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]